Shiny Brands Group (6703) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 軒郁

Shiny Brands Group (6703) reported revenue of NT$334.4 million for Oct 2026, +12.3% year on year and +19.0% from the previous month. Revenue for Jan–Oct 2026 was NT$2.87 billion (+15.5% year on year).

Year-on-year revenue growth: 13 months in a row. →

In Oct 2026, it ranked No. 30 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$273.4 million24/10Nov 2024 NT$513.5 millionDec 2024 NT$212 millionJan 2025 NT$215.9 millionFeb 2025 NT$187.3 million25/02Mar 2025 NT$277 millionApr 2025 NT$288.9 millionMay 2025 NT$263.5 millionJun 2025 NT$278.2 million25/06Jul 2025 NT$199.4 millionAug 2025 NT$266.3 millionSep 2025 NT$206.7 millionOct 2025 NT$297.6 million25/10Nov 2025 NT$533.6 millionDec 2025 NT$272.1 millionJan 2026 NT$238.4 millionFeb 2026 NT$197.7 million26/02Mar 2026 NT$308.4 millionApr 2026 NT$347.5 millionMay 2026 NT$307.8 millionJun 2026 NT$316.2 million26/06Jul 2026 NT$264.2 millionAug 2026 NT$271.2 millionSep 2026 NT$280.9 millionOct 2026 NT$334.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$334.4 million+12.3%+19.0%
Sep 2026NT$280.9 million+35.9%+3.6%
Aug 2026NT$271.2 million+1.8%+2.6%
Jul 2026NT$264.2 million+32.5%-16.4%
Jun 2026NT$316.2 million+13.6%+2.7%
May 2026NT$307.8 million+16.8%-11.4%
Apr 2026NT$347.5 million+20.3%+12.7%
Mar 2026NT$308.4 million+11.3%+56.0%
Feb 2026NT$197.7 million+5.5%-17.1%
Jan 2026NT$238.4 million+10.4%-12.4%
Dec 2025NT$272.1 million+28.4%-49.0%
Nov 2025NT$533.6 million+3.9%+79.3%
Oct 2025NT$297.6 million+8.9%+44.0%
Sep 2025NT$206.7 million-21.2%-22.4%
Aug 2025NT$266.3 million-5.7%+33.5%
Jul 2025NT$199.4 million-17.1%-28.3%
Jun 2025NT$278.2 million-7.7%+5.6%
May 2025NT$263.5 million-27.2%-8.8%
Apr 2025NT$288.9 million-12.9%+4.3%
Mar 2025NT$277 million-13.2%+47.9%
Feb 2025NT$187.3 million-12.5%-13.2%
Jan 2025NT$215.9 million-20.3%+1.9%
Dec 2024NT$212 million-11.7%-58.7%
Nov 2024NT$513.5 million+0.6%+87.8%
Oct 2024NT$273.4 million-2.1%+4.2%

Jan–Oct 2026 cumulative: NT$2.87 billion (+15.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Shiny Brands Group vs PEC / Shiny Brands Group vs Lotus Pharm / Shiny Brands Group vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16